NEW YORK (GenomeWeb News) – Thermo Fisher Scientific recorded about $55.6 million in restructuring charges related to the termination of employees during 2013, the company said in its Form 10-K on Thursday.

The company took charges in its Analytical Technologies segment of $18.5 million; in its Specialty Diagnostics segment of $17.8 million; in its Laboratory and Products Services segment of $16.3 million; and in corporate of $3.0 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: factors influencing retrotransposon integration sites, and more.

A bioethicist argues for the responsible use of germline gene editing.

Some breweries are using DNA-based testing to determine whether unwanted bacteria are affecting their beers, The Verge reports.

Standardized N-of-1 trials will be needed to test out personalized medicines, writes Nicholas Schork from the J. Craig Venter Institute at Nature.